BACKGROUND: Reactive oxygen species (ROS), such as hydrogen peroxide and superoxide, trigger biodegradation of polymer-based nanoparticles (NPs) bearing pinacol-type boronic ester groups. These NPs may selectively release their cargo, in this case paclitaxel (PTX), at the high levels of ROS present in the intracellular environment of inflamed tissues and most tumors. PURPOSE: The main objective was to determine anti-tumor efficacy of PTX-loaded ROS-sensitive NPs and to examine whether macrophage infiltration had any impact on treatment efficacy. METHODS: NPs were synthesized and their characteristics in the presence of H2O2 were demonstrated. Both confocal microscopy as well as flow cytometry approaches were used to determine degradation of ROS-sensitive NPs. HeLa cells were cultured in vitro and used to establish tumor xenografts in nude mice. In vivo experiments were performed to understand toxicity, biodistribution and anti-tumor efficacy of the NPs. Moreover, we performed immunohistochemistry on tumor sections to study infiltration of M1 and M2 subsets of macrophages. RESULTS: We demonstrated that PTX delivered in NPs containing a ROS-sensitive polymer exhibits a better anti-tumor efficacy than PTX in NPs containing ROS-non-sensitive polymer, free PTX or Abraxane® (nab-PTX). The biodistribution revealed that ROS-sensitive NPs exhibit retention in liver, spleen and lungs, suggesting a potential to target cancer metastasizing to these organs. Finally, we demonstrated a correlation between infiltrated macrophage subsets and treatment efficacy, possibly contributing to the efficient anti-tumor effects. CONCLUSION: Treatment with ROS-sensitive NPs containing PTX gave an improved therapeutic effect in HeLa xenografts than their counterpart, free PTX or nab-PTX. Our data revealed a correlation between macrophage infiltration and efficiency of the different antitumor treatments, as the most effective NPs resulted in the highest infiltration of the anti-tumorigenic M1 macrophages.

Department of Biosciences University of Oslo Oslo Norway

Department of Chemistry University of Oslo Oslo Norway

Department of Molecular Cell Biology Institute for Cancer Research Oslo University Hospital The Norwegian Radium Hospital Oslo Norway

Department of Radiation Biology Institute for Cancer Research Oslo University Hospital The Norwegian Radium Hospital Oslo Norway

Department of Tumor Biology Institute for Cancer Research Oslo University Hospital The Norwegian Radium Hospital Oslo Norway

Institute of Macromolecular Chemistry v v i Academy of Sciences of the Czech Republic Prague Czech Republic

Institute of Medical Biology Faculty of Health Sciences The Arctic University of Norway University of Tromsø Tromsø Norway

Zobrazit více v PubMed

D’Autreaux B, Toledano MB. ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. PubMed DOI

Sies H, Stahl W, Sundquist AR. Antioxidant functions of vitamins - Vitamin-E and Vitamin-C, beta-carotene, and other carotenoids. PubMed DOI

Sies H. Oxidative stress - from basic research to clinical-application. PubMed DOI

Minelli A, Bellezza I, Conte C, Culig Z. Oxidative stress-related aging: a role for prostate cancer? PubMed

Giorgio M, Trinei M, Migliaccio E, Pelicci PG. Hydrogen peroxide: a metabolic by-product or a common mediator of ageing signals? PubMed

Di Virgilio F. New pathways for reactive oxygen species generation in inflammation and potential novel pharmacological targets. PubMed DOI

Dugan LL, Quick KL. Reactive oxygen species and aging: evolving questions. PubMed DOI

Muhammad S, Bierhaus A, Schwaninger M. Reactive oxygen species in diabetes-induced vascular damage, stroke, and alzheimer’s disease. PubMed DOI

Touyz RM. Reactive oxygen species and angiotensin II signaling in vascular cells - implications in cardiovascular disease. PubMed DOI

Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. PubMed DOI PMC

Johar R, Sharma R, Kaur A, Mukherjee TK. Role of reactive oxygen species in estrogen dependant breast cancer complication. PubMed DOI

Sharma A, Rajappa M, Satyam A, Sharma M. Oxidant/anti-oxidant dynamics in patients with advanced cervical cancer: correlation with treatment response. PubMed DOI

Chan DW, Liu VWS, Tsao GSW, et al. Loss of MKP3 mediated by oxidative stress enhances tumorigenicity and chemoresistance of ovarian cancer cells. PubMed DOI

Edderkaoui M, Hong P, Vaquero EC, et al. Extracellular matrix stimulates reactive oxygen species production and increases pancreatic cancer cell survival through 5-lipoxygenase and NADPH oxidase. PubMed DOI

Azad N, Rojanasakul Y, Vallyathan V. Inflammation and lung cancer: roles of reactive oxygen/nitrogen species. PubMed DOI

Wang Z, Li Z, Ye Y, Xie L, Li W. Oxidative stress and liver cancer: etiology and therapeutic targets. PubMed DOI PMC

Bur H, Haapasaari K-M, Turpeenniemi-Hujanen T, et al. Oxidative stress markers and mitochondrial antioxidant enzyme expression are increased in aggressive Hodgkin lymphomas. PubMed DOI

Salganik RI, Albright CD, Rodgers J, et al. Dietary antioxidant depletion: enhancement of tumor apoptosis and inhibition of brain tumor growth in transgenic mice. PubMed DOI

Klaunig JE, Xu Y, Isenberg JS, et al. The role of oxidative stress in chemical carcinogenesis. PubMed PMC

Petros RA, DeSimone JM. Strategies in the design of nanoparticles for therapeutic applications. PubMed DOI

Peer D, Karp JM, Hong S, Farokhzad OC, Margalit R, Langer R. Nanocarriers as an emerging platform for cancer therapy. PubMed DOI

Couvreur P. Nanoparticles in drug delivery: past, present and future. PubMed DOI

Skotland T, Iversen TG, Sandvig K. Development of nanoparticles for clinical use. PubMed DOI

Pu HL, Chiang WL, Maiti B, et al. Nanoparticles with dual responses to oxidative stress and reduced ph for drug release and anti-inflammatory applications. PubMed DOI

Dickinson BC, Chang CJ. A targetable fluorescent probe for imaging hydrogen peroxide in the mitochondria of living cells. PubMed DOI PMC

Savina A, Peres A, Cebrian I, et al. The small GTPase Rac2 controls phagosomal alkalinization and antigen crosspresentation selectively in CD8(+) dendritic cells. PubMed DOI

de Gracia Lux C, Joshi-Barr S, Nguyen T, et al. Biocompatible polymeric nanoparticles degrade and release cargo in response to biologically relevant levels of hydrogen peroxide. PubMed DOI PMC

Shim MS, Xia Y. A reactive oxygen species (ROS)-responsive polymer for safe, efficient, and targeted gene delivery in cancer cells. PubMed DOI PMC

Jager E, Hocherl A, Janouskova O, et al. Fluorescent boronate-based polymer nanoparticles with reactive oxygen species (ROS)-triggered cargo release for drug-delivery applications. PubMed DOI

Liou GY, Storz P. Reactive oxygen species in cancer. PubMed DOI PMC

Nathan C, Cunningham-Bussel A. Beyond oxidative stress: an immunologist’s guide to reactive oxygen species. PubMed DOI PMC

Guillen J. FELASA guidelines and recommendations. PubMed PMC

Knapp W, Dorken B, Rieber P, Schmidt RE, Stein H, von dem Borne AE. CD antigens 1989. PubMed DOI

Khazen W, M’Bika JP, Tomkiewicz C, et al. Expression of macrophage-selective markers in human and rodent adipocytes. PubMed DOI

Komohara Y, Fujiwara Y, Ohnishi K, Takeya M. Tumor-associated macrophages: potential therapeutic targets for anti-cancer therapy. PubMed DOI

Wang C, Wang Y, Wang Y, Fan M, Luo F, Qian Z. Characterization, pharmacokinetics and disposition of novel nanoscale preparations of paclitaxel. PubMed DOI

Storz P. Reactive oxygen species in tumor progression. PubMed

Huang D, Zhuang Y, Shen H, Yang F, Wang X, Wu D. Acetal-linked PEGylated paclitaxel prodrugs forming free-paclitaxel-loaded pH-responsive micelles with high drug loading capacity and improved drug delivery. PubMed DOI

Lu J, Chuan X, Zhang H, et al. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo. PubMed DOI

Jager E, Giacomelli FC. Soft matter assemblies as nanomedicine platforms for cancer chemotherapy: a journey from market products towards novel approaches. PubMed DOI

Bargagli E, Olivieri C, Bennett D, Prasse A, Muller-Quernheim J, Rottoli P. Oxidative stress in the pathogenesis of diffuse lung diseases: a review. PubMed DOI

Corzo CA, Cotter MJ, Cheng P, et al. Mechanism regulating reactive oxygen species in tumor-induced myeloid-derived suppressor cells. PubMed DOI PMC

Barja G. Mitochondrial oxygen consumption and reactive oxygen species production are independently modulated: implications for aging studies. PubMed DOI

Logan A, Shabalina IG, Prime TA, et al. In vivo levels of mitochondrial hydrogen peroxide increase with age in mtDNA mutator mice. PubMed DOI PMC

Beckman KB, Ames BN. The free radical theory of aging matures. PubMed DOI

Brand MD. Uncoupling to survive? The role of mitochondrial inefficiency in ageing. PubMed DOI

Pavelescu LA. On reactive oxygen species measurement in living systems. PubMed PMC

Larsen SK, Gao Y, Basse PH. NK cells in the tumor microenvironment. PubMed DOI PMC

Qian BZ, Pollard JW. Macrophage diversity enhances tumor progression and metastasis. PubMed DOI PMC

Mantovani A, Sica A, Locati M. Macrophage polarization comes of age. PubMed DOI

Komohara Y, Jinushi M, Takeya M. Clinical significance of macrophage heterogeneity in human malignant tumors. PubMed DOI PMC

Brown ER, Charles KA, Hoare SA, et al. A clinical study assessing the tolerability and biological effects of infliximab, a TNF-alpha inhibitor, in patients with advanced cancer. PubMed DOI

Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. PubMed DOI PMC

Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. PubMed DOI

Kodumudi KN, Woan K, Gilvary DL, Sahakian E, Wei S, Djeu JY. A novel chemoimmunomodulating property of docetaxel: suppression of myeloid-derived suppressor cells in tumor bearers. PubMed DOI PMC

Fusser M, Overbye A, Pandya AD, et al. Cabazitaxel-loaded Poly(2-ethylbutyl cyanoacrylate) nanoparticles improve treatment efficacy in a patient derived breast cancer xenograft. PubMed DOI

Wanderley CW, Colon DF, Luiz JPM, et al. Paclitaxel reduces tumor growth by reprogramming tumor-associated macrophages to an M1- profile in a TLR4-dependent manner. PubMed DOI